A Phase 1, Single-Center, Randomized, Single-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2017
At a glance
- Drugs SM 04755 (Primary)
- Indications Tendinitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Samumed
- 20 Jun 2017 According to a Samumed media release, the company expects to report the results from this trial at a future conference.
- 20 Jun 2017 Status changed from planning to completed, according to a Samumed media release.
- 26 Nov 2016 New trial record